Pharmacist Diabetes | Weight Management On-Demand 1h

What are the effects of subcutaneous semaglutide added to high daily doses of insulin in patients with type 2 diabetes? Take this course to learn more!

Learning Objectives

Upon successful completion of this application-based course, participants should be able to:
1. List the benefits of decreasing the total daily dose of insulin.
2. Describe the patient population who may benefit most from the addition of semaglutide to high total daily dose insulin therapy.
3. Review the strengths, limitations, and results of the semaglutide trial.
4. Discuss the role of semaglutide as treatment in type 2 diabetes mellitus patients with a high total daily dose of insulin.
5. Apply the results of the semaglutide trial to a patient case.

Article Information

To obtain 1 contact hour of continuing pharmacy education credit (0.1 CEU), participants must read the article cited below.

Meyer J, Dreischmeier E, Lehmann M, Phelan J. The Effects of Adding Semaglutide to High Daily Dose Insulin Regimens in Patients With Type 2 Diabetes. Ann Pharmacother. 2023;57(3):241-250. doi:10.1177/10600280221107381

Faculty

Emily Van Klompenburg, PharmD, BACAP

Assistant Professor
South Dakota State University
College of Pharmacy and Allied Health Professions

Disclosures:

Emily Van Klompenburg has no relevant financial relationships with ineligible companies to disclose.

Course Details